已收盘 10-09 16:00:00 美东时间
-0.010
-0.02%
Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology, today announced it has resubmitted the Marketing Authorisation Application (M...
10-08 20:04
Outperform-rated Scholar Rock Holding Corp. (SRRK) has been added to Wedbush's Best Ideas List as it is "uniquely positioned to deliver a durable, de-risked commercial ramp in the neuromuscular space....
09-26 01:17
今日重点评级关注:Canaccord Genuity:维持Aurora Innovation"买入"评级,目标价从15美元升至17美元;摩根大通:维持皇家加勒比邮轮"超配"评级,目标价从345美元升至394美元
09-25 15:55
Truist Securities analyst Srikripa Devarakonda maintains Scholar Rock Holding (NASDAQ:SRRK) with a Buy and raises the price target from $76 to $77.
09-24 23:56
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
AI医疗概念周内狂飙!Tempus AI劲升32%,CEO释放长期增长指引;TWST升31%,与礼来TuneLab达成合作;FPS升24%,2027财年业绩指引大超预期>>
09-20 09:30
今日重点评级关注:HC Wainwright & Co.:上调Cardiff Oncology评级至"买入",目标价9美元;古根海姆:维持Inventiva"买入"评级,目标价从11美元升至14美元
09-16 16:10
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG cut the price target for Exodus Movement Inc (NYSE:EXOD) from $16 to $12. BTIG analyst Andrew Harte maint...
09-15 20:41
今日重点评级关注:Ascendiant Capital:维持SurgePays"买入"评级,目标价从3.5美元升至3.75美元;HC Wainwright & Co.:维持Spero Therapeutics"买入"评级,目标价从5美元升至6美元
09-15 15:30
Wedbush analyst David Nierengarten reiterates Scholar Rock Holding (NASDAQ:SRRK) with a Outperform and maintains $64 price target.
09-14 20:45